$OGN
Organon & Co.
NYSE · Healthcare · Pharmaceutical Preparations · Jersey City, NJ
OGN chart
What traders are saying about $OGN
Latest postsOrganon & Co. news
- Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
Yahoo Finance ·
- Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance ·
- Weekly Recap: Sun Pharma deal for Organon & Co. and No Q3 '26 milestones
TradingView ·
- Organon & Co. (OGN) Holds at $13.75 as Shares Consolidate Between Key Levels - Bear Flag
https://www.dars.gov.et/ ·
- Organon & Co. Estimates – NYSE:OGN
TradingView ·
- Top Organon & Co. (OGN) Competitors 2026
MarketBeat ·
- OGN Q3'26 Earnings: revenue estimate is 1.58B USD
TradingView ·
- Organon & Co. (OGN) Stock Forecasts
Yahoo Finance ·
- Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
Yahoo Finance ·
- Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting
Yahoo Finance ·
- Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Yahoo Finance ·
- Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Yahoo Finance ·
Organon & Co. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $6.22B | $6.40B | $6.26B | $6.17B |
| Net income | $187.0M | $864.0M | $1.02B | $917.0M |
| Diluted EPS | $0.72 | $3.33 | $3.99 | $3.59 |
| Total assets (year end) | $12.87B | $13.10B | $12.06B | $10.96B |
| Cash and equivalents (year end) | $574.0M | $675.0M | $693.0M | $706.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Organon & Co.
- Ticker
- OGN (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Jersey City, NJ
- Fiscal year end
- December 31
- SEC CIK
- 1821825
Frequently asked questions
What exchange is Organon & Co. listed on?
Organon & Co. trades on the NYSE under the ticker symbol OGN.
What industry is Organon & Co. in?
Organon & Co. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Organon & Co. headquartered?
Organon & Co.'s business address on file with the SEC is in Jersey City, NJ.
When does Organon & Co.'s fiscal year end?
Organon & Co.'s fiscal year ends on December 31.
How much revenue did Organon & Co. report?
Organon & Co. reported $6.22B in revenue for calendar year 2025, according to its SEC filings.